| scholarly article | Q13442814 |
| P50 | author | Thomas M Piers | Q83512339 |
| Daniel J. Whitcomb | Q42184106 | ||
| Kwangwook Cho | Q56542905 | ||
| Philip Regan | Q58325472 | ||
| P2093 | author name string | Se Jin Park | |
| Jong Hoon Ryu | |||
| Dong-Hyun Kim | |||
| Jee-Hyun Yi | |||
| Seonghoo Huh | |||
| P2860 | cites work | A protein factor essential for microtubule assembly | Q22010837 |
| Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade | Q24561819 | ||
| PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | Q27863894 | ||
| Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models | Q28119018 | ||
| LTP inhibits LTD in the hippocampus via regulation of GSK3beta | Q28290606 | ||
| NMDA receptor activation suppresses microtubule growth and spine entry | Q28565444 | ||
| PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity | Q28574179 | ||
| PICK1 inhibition of the Arp2/3 complex controls dendritic spine size and synaptic plasticity | Q28579179 | ||
| Microtubule-associated protein tau is essential for long-term depression in the hippocampus | Q28584008 | ||
| A simple method for organotypic cultures of nervous tissue | Q29614375 | ||
| Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology | Q29617284 | ||
| Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model | Q29617937 | ||
| Tau-mediated neurodegeneration in Alzheimer's disease and related disorders | Q29618148 | ||
| Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. | Q30010481 | ||
| Dynamic association of tau with neuronal membranes is regulated by phosphorylation | Q30155626 | ||
| Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases | Q30157679 | ||
| Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions | Q31101529 | ||
| Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes | Q33838732 | ||
| A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors | Q33953387 | ||
| Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. | Q34019051 | ||
| Ras and Rap control AMPA receptor trafficking during synaptic plasticity | Q34146651 | ||
| Synapses and memory storage | Q34267645 | ||
| Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism | Q34499909 | ||
| Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration | Q34518577 | ||
| Hippocampal long-term depression: master or minion in declarative memory processes? | Q34603571 | ||
| Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility | Q34768889 | ||
| Novelty acquisition is associated with induction of hippocampal long-term depression. | Q35563686 | ||
| The Jak/STAT pathway is involved in synaptic plasticity | Q35713202 | ||
| The many faces of tau | Q35870359 | ||
| Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors | Q36213686 | ||
| An essential role for PICK1 in NMDA receptor-dependent bidirectional synaptic plasticity | Q36586635 | ||
| The importance of tau phosphorylation for neurodegenerative diseases | Q36968220 | ||
| Post-translational modifications of tau protein: implications for Alzheimer's disease. | Q37826875 | ||
| Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation | Q37903257 | ||
| Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons | Q38342193 | ||
| PICK1 is a calcium-sensor for NMDA-induced AMPA receptor trafficking | Q41857630 | ||
| Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation | Q42130064 | ||
| A novel mechanism of hippocampal LTD involving muscarinic receptor-triggered interactions between AMPARs, GRIP and liprin-alpha | Q42184020 | ||
| Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules | Q43273610 | ||
| Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau. | Q43616611 | ||
| Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus | Q44524418 | ||
| Glutamate Receptor Subunit 2 Serine 880 Phosphorylation Modulates Synaptic Transmission and Mediates Plasticity in CA1 Pyramidal Cells | Q44610940 | ||
| Hippocampal long-term depression mediates spatial reversal learning in the Morris water maze. | Q45265257 | ||
| Neuronal transfection in brain slices using particle-mediated gene transfer. | Q45271926 | ||
| Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease | Q45328065 | ||
| Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome | Q45865881 | ||
| Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation | Q46412461 | ||
| PI3Kγ is required for NMDA receptor-dependent long-term depression and behavioral flexibility | Q48034381 | ||
| Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease | Q48189763 | ||
| Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding | Q48277664 | ||
| NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus | Q48327089 | ||
| Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease | Q48341418 | ||
| Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. | Q48394153 | ||
| Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. | Q48686425 | ||
| Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. | Q53199978 | ||
| Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. | Q54613756 | ||
| Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments | Q59488574 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 4804-4812 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Tau phosphorylation at serine 396 residue is required for hippocampal LTD | |
| P478 | volume | 35 |
| Q49913378 | A role for tau in learning, memory and synaptic plasticity |
| Q92946509 | ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease |
| Q50420723 | AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy |
| Q36941624 | AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo |
| Q47836602 | AMPA Receptor Trafficking in Natural and Pathological Aging |
| Q36637069 | Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF) |
| Q41625585 | Age-dependent changes in synaptic plasticity enhance tau oligomerization in the mouse hippocampus. |
| Q46240783 | Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies. |
| Q26748723 | Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking |
| Q47145684 | Atypical, non-standard functions of the microtubule associated Tau protein |
| Q99578886 | Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis |
| Q47119516 | Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins. |
| Q40083148 | Determination of the Best Concentration of Streptozotocin to Create a Diabetic Brain Using Histological Techniques. |
| Q41071847 | Dysregulation of Microtubule Stability Impairs Morphofunctional Connectivity in Primary Neuronal Networks |
| Q27336341 | Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau |
| Q91867217 | Enhanced Tau Protein Translation by Hyper-Excitation |
| Q50090238 | Fluoxetine Inhibits Natural Decay of Long-Term Memory via Akt/GSK-3β Signaling. |
| Q91635049 | GSK3β and Tau Protein in Alzheimer's Disease and Epilepsy |
| Q38954686 | Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders |
| Q90286851 | Introduction of Tau Oligomers into Cortical Neurons Alters Action Potential Dynamics and Disrupts Synaptic Transmission and Plasticity |
| Q50703202 | Is riluzole a new drug for Alzheimer's disease? |
| Q92886566 | Loss of tau and Fyn reduces compensatory effects of MAP2 for tau and reveals a Fyn-independent effect of tau on calcium |
| Q38713424 | Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease |
| Q26750922 | New Features about Tau Function and Dysfunction |
| Q92554699 | Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia |
| Q39752041 | Novel function of Tau in regulating the effects of external stimuli on adult hippocampal neurogenesis |
| Q26747019 | Palmitoylation in Alzheimer's disease and other neurodegenerative diseases |
| Q60045951 | Phosphorylation of nuclear Tau is modulated by distinct cellular pathways |
| Q38747530 | Physiological and Pathophysiological Implications of Synaptic Tau. |
| Q58699970 | Postsynaptic p47phox regulates long-term depression in the hippocampus |
| Q47420946 | Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'. |
| Q48000590 | Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease |
| Q63345230 | Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology |
| Q26774762 | Sex Hormones Regulate Cytoskeletal Proteins Involved in Brain Plasticity |
| Q58582917 | Synaptic distributions of pS214-tau in rhesus monkey prefrontal cortex are associated with spine density, but not with cognitive decline |
| Q64236054 | Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges |
| Q26773154 | Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease |
| Q26769957 | Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies |
| Q93000935 | Tau is required for the function of extrasynaptic NMDA receptors |
| Q42481832 | Tau phosphorylation-associated spine regression does not impair hippocampal-dependent memory in hibernating golden hamsters. |
| Q99711174 | Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity |
| Q47689697 | Tau-based therapies in neurodegeneration: opportunities and challenges |
| Q28831067 | Tau-mediated synaptic damage in Alzheimer's disease |
| Q26768223 | Tau: The Center of a Signaling Nexus in Alzheimer's Disease |
| Q99711176 | Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches |
Search more.